Protective effects of isolecanoric acid on neurodegenerative in vitro models. (February 2016)
- Record Type:
- Journal Article
- Title:
- Protective effects of isolecanoric acid on neurodegenerative in vitro models. (February 2016)
- Main Title:
- Protective effects of isolecanoric acid on neurodegenerative in vitro models
- Authors:
- de Pedro, Nuria
Cantizani, Juan
Ortiz-López, Francisco Javier
González-Menéndez, Victor
Cautain, Bastien
Rodríguez, Lorena
Bills, Gerald F.
Reyes, Fernando
Genilloud, Olga
Vicente, Francisca - Abstract:
- Abstract: Parkinson's disease (PD) and Amyotrophic lateral sclerosis (ALS), are neurodegenerative disorders characterized by loss of dopaminergic or motor neurons, respectively. Although understanding of the PD and ALS pathogenesis remains incomplete, increasing evidence from human and animal studies has suggested that aberrant GSK3β, oxidative stress and mitochondrial damage are involved in their pathogenesis. Using two different molecular models, treatment with L-BMAA for ALS and rotenone for PD the effect of isolecanoric acid, a natural product isolated from a fungal culture, was evaluated. Pre-treatment with this molecule caused inhibition of GSK3β and CK1, and a decrease in oxidative stress, mitochondrial damage, apoptosis and cell death. Taken together, these results indicated that isolecanoric acid might have a protective effect against the development of these neurodegenerative disorders. Highlights: Parkinson's disease (PD) and Amyotrophic lateral sclerosis (ALS). Aberrant GSK3β, oxidative stress and mitochondrial damage. Isolecanoric acid, caused inhibition of GSK3β, decrease oxidative stress. Isolecanoric acid decreased mitochondrial damage, apoptosis and cell death. Isolecanoric acid might have a protective neurodegenerative effect.
- Is Part Of:
- Neuropharmacology. Volume 101(2016)
- Journal:
- Neuropharmacology
- Issue:
- Volume 101(2016)
- Issue Display:
- Volume 101, Issue 2016 (2016)
- Year:
- 2016
- Volume:
- 101
- Issue:
- 2016
- Issue Sort Value:
- 2016-0101-2016-0000
- Page Start:
- 538
- Page End:
- 548
- Publication Date:
- 2016-02
- Subjects:
- Isolecanoric acid -- Parkinson's disease -- ALS disease -- Natural products -- Neurodegenerative disorders -- Rotenone -- GSK3β -- L-BMAA
Neuropsychopharmacology -- Periodicals
Autonomic Agents -- Periodicals
Neuropsychopharmacologie -- Périodiques
Neuropsychopharmacology
Periodicals
Electronic journals
615.78 - Journal URLs:
- http://www.sciencedirect.com/science/journal/00283908 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.neuropharm.2015.09.029 ↗
- Languages:
- English
- ISSNs:
- 0028-3908
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 6081.517500
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 1265.xml